M MaxCyte® Driving the Next Generation of Cell-Based Therapies MaxCyte Corporate Presentation NASDAQ: MXCT • LSE: MXCT May, 9 2022 are trademarks of MaxCyte, Inc. in the U.S.A. ® ® ® ® TM © 2019 MaxCyte, Inc. All Rights Reserved info@maxcyte.com | www.maxcyte.com ir@maxcyte.com | www.maxcyte.com Disclaimer The content of this document (the "Presentation") has not been approved by an authorized person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"), as amended. Reliance on this doc ...